Shaw Christi bought KYTX
January 12, 2026 · Form 4 insider transaction
Shaw Christi bought 24,301 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,301
Price
$0.00
Total value
N/A
InsiderShaw Christi
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after70,935
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share.